By Dawn Kopecki, Jarrett Renshaw, Sabrina Valle and Ernest Scheyder NEW YORK, October 2 (Reuters) -Eli Lilly was asked to ...

By Charlie Conchie LONDON (Reuters) -AstraZeneca’s move to upgrade its listing in the U.S. risks pulling liquidity away from ...

Shares of AstraZeneca (NASDAQ: AZN) have jumped more than 10% this week. On Monday, the British drugmaker reported positive results from a clinical study of Enhertu in treating HER2-positive early ...

Eli Lilly was asked to produce more insulin; Pfizer to produce more of its top-selling cancer drug Ibrance and its ...

Thermo Fisher Scientific announced an R&D partnership with AstraZeneca BioVentureHub. Crinetics received FDA approval of Palsonify (paltusotine) to treat acromegaly in adults. The agency approved ...

AstraZeneca saw its share prices jump to a new all-time high on Wednesday, as investors cheered reports that President Donald ...

The company was one of many to get letters last month from the US Food and Drug Administration calling out what the agency ...

This story was originally published by Grist with the headline In Arizona, a fight against a deadly fungus is under threat ...

Ten stocks finished the trading session with hefty gains, mirroring a broader market optimism following President Donald ...

In today's Pharmalittle roundup, we're reading about delayed pharma tariffs, how the government shutdown affects FDA, and ...

New data centers and service centers designed to enhance infrastructure coverage and stay ahead of global growing demand for ...